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Using polymerase chain reaction and sequencing, we investi-
gated the prevalence of Rickettsia prowazekii, Bartonella quin-
tana, and Borrelia recurrentis in 841 body lice collected from
various countries. We detected R. prowazekii in body lice from
Burundi in 1997 and in lice from Burundi and Rwanda in 2001;
B. quintana infections of body lice were widespread. We did not
detect B. recurrentis in any lice.
he body louse, Pediculus humanus corporis, is the vector
of three human pathogens: Rickettsia prowazekii, the
agent of epidemic typhus; Borrelia recurrentis, the agent of
relapsing fever; and Bartonella quintana, the agent of trench
fever, bacillary angiomatosis, endocarditis, chronic bactere-
mia, and chronic lymphadenopathy (1). Louse-borne diseases
can be associated with high incidence of disease and death,
especially epidemic typhus and relapsing fever, which can be
fatal in up to 40% of patients (2). The diseases are mostly
prevalent in people living in poverty and overcrowded condi-
tions, for example, homeless people and those involved in war
situations (2).
Epidemic typhus, trench fever, and relapsing fever have
been the subject of many studies, most of which were con-
ducted between World War I and the 1960s. However, medical
interest in the diseases and lice waned for almost 30 years.
Since 1995 louse-borne diseases have had a dramatic resur-
gence, and trench fever has been diagnosed in many countries
including the USA (3), Peru (4), France (5), Russia (6), and
Burundi (7). In 1997 the largest outbreak of epidemic typhus
since World War II occurred in Burundi among refugees dis-
placed by civil war (7). A small outbreak also occurred in Rus-
sia (8), and evidence of R. prowazekii infection in Algeria was
provided (9).
At the Unité des Rickettsies, we developed a polymerase
chain reaction (PCR) assay to survey for human pathogens
transmitted by the parasites; the assay can detect as few as 1–20
copies of the DNA of R. prowazekii, B. quintana, and Borrelia
recurrentis in body lice (10). In 1995, we found R. prowazekii–
positive lice in inmates of a Burundi jail (11), which was the
source of a major outbreak of epidemic typhus in the country in
1996 (12). In 1997, we investigated an outbreak of pediculosis
in refugee camps in Burundi. We identified R. prowazekii and
B. recurrentis in body lice and epidemic typhus and trench
fever in refugees (7,10). From April 1997 to December 1998,
after our reports, a new strategy was designed to control typhus
and trench fever. Health workers treated any patient with fever
>38.5°C with a single dose of doxycycline (200 mg), a drug
highly effective in the treatment of typhus (7). The program
proved extremely successful, and in a follow-up in 1998 (10)
we did not detect R. prowazekii in body lice collected in refu-
gee camps in the country (Table 1).
Since 1998, we have continued our efforts and have col-
lected 841 body lice obtained by medical staff from our labo-
ratory or local investigators in Burundi, Rwanda, France,
Tunisia, Algeria, Russia, Peru, China, Thailand, Australia,
Zimbabwe, and the Netherlands (Table 1). In Burundi, lice
were collected during the outbreak of epidemic typhus and on
three occasions (1998, 2000, and 2001) after the outbreak had
been controlled. Lice found on any part of the body, except the
head and pubis, were regarded as body lice. The lice were
transported to France in sealed, preservative-free, plastic tubes
at room temperature. Delays between collection and analysis
ranged from 1 day to 6 months. As negative controls, we used
specific pathogen-free laboratory-raised body lice (Pediculus
humanus corporis strain Orlando). To prevent contamination
problems, as positive controls we used DNA from R. rickettsii
R (ATCC VR-891), Bartonella elizabethae F9251 (ATCC
49927), and Borrelia burgdorferi B31 (ATCC 35210), which
would react with the primer pairs we used in our PCRs but
give sequences distinct from the organisms under investiga-
tion. To prevent false-positive reactions from surface contami-
nants, each louse was immersed for 5 min in a solution of 70%
ethanol–0.2% iodine before DNA extraction and then washed
for 5 min in sterile distilled water. After each louse was
crushed individually in a sterile Eppendorf tube with the tip of
a sterile pipette, DNA was extracted by using the QIAamp Tis-
sue Kit (Qiagen, Hilden, Germany), according to the manufac-
turer’s instructions. This kit was also used to extract DNA
from the organisms cultivated in our laboratory under standard
conditions to be used as positive controls. The effectiveness of
the DNA extraction procedure and the absence of PCR inhibi-
tors were determined by PCR with broad-range 18S rDNA-
derived primers (10).
To detect louse-transmitted pathogens, we used each of the
genus-specific primer pairs described in Table 2 in a separate
assay. A total of 2.5 mL of the extracted DNA was used for
DNA amplification as previously described (10). PCRs were
carried out in a Peltier Thermal Cycler PTC-200 (MJ
Research, Inc., Watertown, MA). PCR products were resolved
by electrophoresis in 1% agarose gels. All lice yielded positive
PCR products when amplified with the 18S rRNA-derived
primers, demonstrating the absence of PCR inhibitors. Nega-
tive controls always failed to yield detectable PCR products,
whereas positive controls always gave expected PCR products.
PCR amplicons were purified by using the QIAquick Spin
PCR purification kit (Qiagen) and sequenced using the
dRhodamine Terminator cycle-sequencing ready reaction kit
(PE Applied Biosystems, Les Ulis, France), according to the
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manufacturer’s recommendations. Sequences obtained were
compared with those in the GenBank DNA database by using
the program BLAST (14).
The sequences of the DNA amplicons we obtained were
identical to those of R. prowazekii and B. quintana in Gen-
Bank. We detected R. prowazekii in body lice collected in
Burundi in 2001 but not in those collected in 1998 and 2000,
although they were positive for B. quintana. R. prowazekii was
also detected in 7% of lice collected in Rwanda. We found B.
quintana  in body lice collected in France, the Netherlands,
Russia, Burundi, Rwanda, Zimbabwe, and Peru. No PCR
products were obtained for any of the lice when primer pair
Bf1-Br1 was used, indicating lack of infections with Borrelia
recurrentis. 
Our PCR may greatly facilitate the study of lice and louse-
borne diseases as it can be used to survey lice for these organ-
isms, detect infected patients, estimate the risk for outbreaks,
follow the progress of epidemics, and justify the implementa-
Table 1. Prevalences of infections in body lice collected in various areas of the world
Detectiona of
Country Source, yr Referenceb No. Rickettsia prowazekii (no., %) Bartonella quintana (no., %)
Body lice
France  Homeless in Marseille, 1998–2001 PSc 324 0 32 (9.9%)
France Homeless shelter in Marseille, 2000 (13) 161 0 42 (26.1%) 
France Isolated homeless in Marseille, 1998 (10) 75 0 3 (4.0%) 
The Netherlands Homeless in Utrecht, 2001 PS 25 0 9 (36.0%) 
Russia Homeless in Moscow, 1998 (10) 268 0 33 (12.3%)
Tunisia Homeless in Sousse, 2000 PS 3 0 0
Algeria Homeless in Batna, 2001 PS 33 0 0
Congo Refugee camp, 1998 (10) 7 0 0
Burundi During typhus outbreak
Jail, 1997 (10) 10 2 (20%) 0
Refugee camp, 1997 (10) 63 22 (35%) 6 (9.5%)
After typhus outbreak
Refugee camp, 1998 (10) 91 0 13 (14.3%)
Refugee camp, 1998 PS 38 0 8 (21.0%)
Refugee camp, 2000 PS 111 0 100 (90%)
Refugee camp, 2001 PS 33 7 (21%) 31 (93.9%)
Rwanda Jail, 2001 PS 262 19 (7%) 6 (2.3%)
Zimbabwe Homeless in Harare, 1998 (10) 12 0 2 (16.7%)
Australia Homeless in , 2001 PS 2 0 0
Peru Andean rural population (10) 73 0 1 (1.4%)
Peru Andean rural population PS 10 0 0
Head lice
France Schoolchildren PS 20 0 0
Portugal Schoolchildren PS 20 0 0
Russia Schoolchildren PS 10 0 0
Algeria Schoolchildren PS 18 0 0
Burundi Schoolchildren PS 20 0 0
China Schoolchildren PS 23 0 0
Thailand Schoolchildren PS 29 0 0
Australia Schoolchildren PS 3 0 0
aBorrelia recurrentis could not be detected in any of the tested lice.
bData previously reported in the indicated reference.
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tion of controls to prevent the spread of infections. We have
successfully applied the PCR assay to lice from homeless and
economically deprived persons in inner cities of developed
countries and found high prevalences of Bartonella quintana
infections (3,5,6). Furthermore, we have emphasized the risk
of R. prowazekii outbreaks in Europe, based on our findings of
an outbreak of epidemic typhus in Russia, a case of Brill-Zins-
ser disease in France (15), and a case of epidemic typhus
imported from Algeria (9). 
The PCR assay on lice may help detect outbreaks. In
recent epidemics of louse-borne infections, the prevalence of
body louse infestations in persons has reached 90% to 100%
before clinical signs of louse-borne disease were noted in the
population (16). Experience has shown that the emergence and
dissemination of body lice can be very rapid when conditions
are favorable (17). In Central Africa, large outbreaks of lice
infections occurred during civil wars in Burundi, Rwanda, and
Zaire (16) and preceded the outbreak of epidemic typhus by 2
years (7). We clearly demonstrate the potential for further out-
breaks of louse-borne diseases in Africa. Although lice from
Burundi were negative for R. prowazekii in 1998 and 2000 as a
result of the administration of doxycycline to patients, the per-
sistence of the vector enabled the spread of R. prowazekii from
human carriers back into the louse population. In 2001, we
found that 21% of lice from refugee camps in the same areas
of Burundi as sampled earlier were positive by PCR for R.
prowazekii. Further samples submitted to our laboratory indi-
cate a typhus outbreak is currently developing in refugee
camps in Burundi (unpub. data). We also found R. prowazekii
in 7% of body lice collected in 2001 from a jail in Rwanda.
That the country is now host to 300,000 refugees from the Jan-
uary 2002 eruption of the Nyiragongo volcano is thus a con-
cern.
Although lice from the other areas studied were free from
typhus, we found B. quintana to be widely distributed; it was
detectable in lice from France, the Netherlands, Burundi, Zim-
babwe, and Rwanda. We could not find the organism in lice
from Australia, Tunisia, and Algeria, but only small numbers
of lice from these areas were studied. As with R. prowazekii,
chronic bacteremia occurs with B. quintana infection in
humans; the only way to eradicate the organism is to eliminate
body lice. We were not able to detect Borrelia recurrentis in
any of the lice, which indicates that infection rates with this
organism are very low or the agent is restricted to specific geo-
graphic zones.
Our study has demonstrated the usefulness of PCR of body
lice in ongoing surveillance of louse-associated infections.
When faced with outbreaks of body lice or to follow-up out-
breaks of louse-borne infections, investigators should consider
using PCR for R. prowazekii, Bartonella quintana, and Borre-
lia recurrentis in body lice collected from the study area and
shipped to their laboratories. Our results from Burundi high-
light the necessity for using combinations of methods to con-
trol body lice and hence R. prowazekii infections.
Dr. Fournier is a physician in the French reference center for the
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